MCL1 and breast carcinoma: Recently OTS167 has been shown to inhibit the MELK-dependent phosphorylation of eIF4B in human breast cancer cell lines, which resulted in downregulation of anti-apoptotic factor myeloid cell leukemia 1 (MCL-1) expression30.